Biotech news
Americas
Biopharmaceutical company Kite, a subsidiary of Gilead, and immunotherapy development company Gadeta announced on Thursday, July 19 that they have entered into a strategic collaboration to produce cancer therapies. 23 July 2018
Biotech
Novartis has signed a global licensing agreement with two biotechnology companies centring on the development of an antibody treatment for inflammatory skin conditions. 20 July 2018
Americas
Raymond Chen and Kathleen O’Malley were selected in the LSIPR 50 2018 publication for their influence on the life sciences industry. They featured in the government and policy section, as LSIPR reports. 20 July 2018
Americas
Sanofi has partnered with biotechnology company Revolution Medicines to develop treatments for multiple cancers. 19 July 2018
Americas
US-based law firm Cantor Colburn has hired Bryan Zerhusen as a partner and chair of the firm’s life sciences practice group. 19 July 2018
Americas
The US Food and Drug Administration is not going to play regulatory ‘whack-a-mole’ with companies trying to delay or derail the entry of biosimilar competitors, according to Scott Gottlieb, commissioner of the FDA. 19 July 2018
Americas
US-based biopharmaceutical company AbbVie entered into a patent licensing agreement with generics company Mylan yesterday. 18 July 2018
Americas
A CRISPR patent owned by the Broad Institute of Harvard and MIT is “unpatentable for indefiniteness”, according to an agriculture biotech company. 18 July 2018
Americas
Josh Makower, partner at venture capital investor New Enterprise Associates, explains to LSIPR the firm’s role in supporting medtech innovation, his sweet spot when it comes to projects, and how to balance what is medically relevant with commercial viability. 17 July 2018
Americas
In the area of precision medicine, there are questions surrounding what data is needed, how it is used, what it should look like and what concerns there are for patients and society, as Daniel Lim of Kirkland & Ellis reports. 17 July 2018